Human medicines European public assessment report EPAR Trisenox arsenic trioxide Leukemia Promyelocytic Acute Date of authorisation 05032002 Revision 26 Status Authorised

Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Leukemia, Promyelocytic, Acute, Date of authorisation: 05/03/2002, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Leukemia, Promyelocytic, Acute, Date of authorisation: 05/03/2002, Revision: 26, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Leukemia, Promyelocytic, Acute, Date of authorisation: 05/03/2002, Revision: 26, Status: Authorised"